News | June 09, 2010

Single Dose IORT for Breast Tumors Found Effective

Intraoperative Radiotherapy (IORT) is used for accelerated, partial breast irradiation.

June 9, 2010 - A single radiation dose during intraoperative radiotherapy (IORT) is at least as effective as longer post-operative treatments, according to results from a study presented at the American Society of Clinical Oncology (ASCO) meeting, held June 4-8 in Chicago and published in the Lancet June 5.

In the study, TARGIT (targeted intraoperative radiotherapy), the radiation therapy is confined to the area of the breast where the tumor has been removed. Researchers reported that TARGIT is as effective at preventing breast cancer recurrence as whole breast radiotherapy and can be completed in one hospital visit.

After surgery to conserve the breast, 90 percent of cancer recurrences occur very near to where the removed tumor was (index quadrant), despite the presence of multicentric cancers elsewhere in the breast. Researchers suggested restriction of radiation therapy to the site of the tumor bed during surgery may be suitable for selected patients. The authors compared targeted intraoperative radiotherapy with the conventional policy of whole breast external beam radiotherapy.

The trial enrolled women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.

A total of 1,113 patients were randomly allocated to targeted intraoperative radiotherapy and 1,119 were allocated to external beam radiotherapy.

Of 996 patients who received the allocated treatment in the targeted intraoperative radiotherapy group:

- 854 (86 percent) received targeted intraoperative radiotherapy only
- 142 (14 percent) received targeted intraoperative radiotherapy plus external beam radiotherapy

There were 1,025 (92 percent) patients in the external beam radiotherapy group received the allocated treatment.

At four years, there were:

- Six local recurrences (of cancer) in the intraoperative radiotherapy group
- Five local recurrences (of cancer) in the external beam radiotherapy group

Occurrence rates in the two groups were similar; 1-20 percent in the targeted intraoperative radiotherapy and 0-95 percent in the external beam radiotherapy group.

The researchers found targeted intraoperative radiotherapy almost completely avoids irradiation of the intrathoracic structures such as the heart, lung, and oesophagus. Consequently, the damage to these structures, which can occur even with modern external beam radiotherapy, will have been avoided.

They wrote in their conclusion: "For selected patients with early breast cancer, a single dose of radiotherapy delivered at the time of surgery by use of targeted intraoperative radiotherapy should be considered as an alternative to external beam radiotherapy delivered over several weeks."

Reference: Vaidya, J., et al. "Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, noninferiority phase 3 trial." The Lancet. June 5, 2010. DOI:10.1016/S0140-6736(10)60837-9

For more information:

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Overlay Init